Integrative genomic profiling of human prostate cancer.
Integrative genomic profiling of human prostate cancer.
复制标题
DOI:
10.1016/j.ccr.2010.05.026
复制
发表时间:
2010-07-13
期刊:
影响因子:
50.3
通讯作者:
Gerald WL
中科院分区:
文献类型:
--
作者:
Taylor BS;Schultz N;Hieronymus H;Gopalan A;Xiao Y;Carver BS;Arora VK;Kaushik P;Cerami E;Reva B;Antipin Y;Mitsiades N;Landers T;Dolgalev I;Major JE;Wilson M;Socci ND;Lash AE;Heguy A;Eastham JA;Scher HI;Reuter VE;Scardino PT;Sander C;Sawyers CL;Gerald WL
Annotation of prostate cancer genomes provides a foundation for discoveries that can impact disease understanding and treatment. Concordant assessment of DNA copy number, mRNA expression, and focused exon resequencing in 218 prostate cancer tumors identified the nuclear receptor coactivator NCOA2 as an oncogene in ~11 percent of tumors. Additionally, the androgen-driven TMPRSS2-ERG fusion was associated with a previously unrecognized, prostate-specific deletion at chromosome 3p14 that implicates FOXP1, RYBP and SHQ1 as potential cooperative tumor suppressors. DNA copy-number data from primary tumors revealed that copy-number alterations robustly define clusters of low- and high-risk disease beyond that achieved by Gleason score. The genomic and clinical outcome data from these patients is now made available as a public resource.
登录
查看更多内容
影响因子:
30.8
作者:
Carver, Brett S.;Tran, Jennifer;Gopalan, Anuradha;Chen, Zhenbang;Shaikh, Safa;Carracedo, Arkaitz;Alimonti, Andrea;Nardella, Caterina;Varmeh, Shohreh;Scardino, Peter T.;Cordon-Cardo, Carlos;Gerald, William;Pandolfi, Pier Paolo
通讯作者:
Pandolfi, Pier Paolo
影响因子:
64.8
作者:
通讯作者:
--
影响因子:
11.2
作者:
Agoulnik, IU;Vaid, A;Weigel, NL
通讯作者:
Weigel, NL
影响因子:
45.3
作者:
Cooperberg, MR;Moul, JW;Carroll, PR
通讯作者:
Carroll, PR
影响因子:
4.4
作者:
He, WW;Sciavolino, PJ;Carter, KC
通讯作者:
Carter, KC